Vision: To determine the mechanisms underpinning how cell-matrix interactions control normal tissue formation and function, and how their disruption causes disease.
This year as part of the British Science Week celebrations, the Centre along with colleagues from across FBMH took over Manchester Museum for the Body Experience. With people waiting for the doors to open at 10am, the visitors were non-stop! The Thornton, Lennon, Streuli, Gilmore and Swift labs worked incredibly hard entertaining and inspiring the public all day. We saw over 2000 visitors, handed out 750 passports and 500 bags, hosted over 80 researchers across 18 stands with 12 volunteers Read more
Congratulations to Christoph Ballestrem, Martin Humphries and Mark Travis on their successful BBSRC grant applications! The Centre held it’s summer symposium on 15 June and a big thank you to all the postdocs and students who responded to the call for abstracts. A small team of Group Leaders selected 6 talks that represent research across the Centre. The quality of the abstracts was superb and it was a difficult task to select just 6 (see photo, from L-R: Hamish Gilbert, Richa Garva, Charlene Read more
The Wellcome Centre for Cell-Matrix Research will host the sixth of our popular Get Connected Research symposia and this year the focus will be Matrix in Fibrosis. There will be 3 thematic sessions covering Mechano- Immuno- and Disease-matrix and we have an excellent faculty of invited speakers. Read more
New research has for the first time shown that our spinal discs have 24-hour body clocks which when they malfunction, can contribute to lower back pain. Lower back pain is amongst the most prevalent spinal diseases associated with increasing age, with over 80% of the UK population predicted to experience back pain within their lifetime. Progressive degeneration of the spine disc is a major contributing factor. Ageing and inflammation are major causes of disc degeneration and lower back pain. In Read more
We have discovered that in addition to CCL5, CXCL8 and CXCL11, TSG-6 interacts with at least 7 other chemokines (i.e. CCL2, CCL7, CCL19, CCL21, CCL27, CXCL4, and CXCL12) including those involved in both homeostatic and inflammatory functions. TSG-6 interacts (via its Link module) with the GAG-binding site on the chemokines, thereby inhibiting the binding of chemokines to GAGs and their presentation on endothelial cells; TSG-6 also inhibits the binding of chemokines to collagen, providing another Read more